News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

February 23, 2021

Demetrix Signs First CMO Partner for Commercial Scale Production of Rare Cannabinoids

Link

February 19, 2021

CalWave Wins DoE National Renewable Energy Laboratory Waves to Water Prize

Link

February 16, 2021

Nexilico and Microvi Biotech Inc. awarded $1.12M by the National Institutes of Health

Link

February 13, 2021

GenEdit Hones in on Nervous System Disorders

Link

February 12, 2021

Lucira Health's COVID-19 Molecular Testing Kits Dubbed the Gold Standard

Link

February 3, 2021

C. Light Technologies Raises $2.5M Seed Round to Commercialize First Ever Retinal Eye-tracking Device for Neurodegenerative Disease

Link

January 28, 2021

Mammoth Biosciences Teams with Agilent to Deliver CRISPR-based Coronavirus Tests

Link

January 14, 2021

Mammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms

Link

January 7, 2021

Nurix Therapeutics Expands Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies

Link

December 9, 2020

New Type of Magnetic Sensor Could Make High-Performance Brain Imaging More Affordable and Portable

Link

December 3, 2020

Infinite Uptime Raises $5.15 Million in Funding

Link

November 30, 2020

Spotlight Therapeutics Closes $30 Million Series A to Advance CRISPR Technology

Link

November 20, 2020

Correlia Biosystems Closes $7M Series A to Enable Product Launch

Link

November 19, 2020

Aclima Series B to Accelerate Climate Innovation for Clean Air and Public Health

Link

November 12, 2020

Exoskeleton-assisted Walking Improves Mobility in Individuals with Spinal Cord Injury

Link

November 10, 2020

Picoyune Wins Gold at the Artisanal Mining Challenge

Link

October 30, 2020

Astellas Completes Acquisition of iota Biosciences

https://www.astellas.com/en/news/16151

October 29, 2020

Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

https://www.genomeweb.com/business-news/mammoth-bio-signs-commercializat...

Novartis Acquires Vedere Bio, Adding Novel Optogenetic Gene Therapy Technology for Treating Blindness

Link

October 26, 2020

Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine

Link